Disclosures for "The Impact of Ampreloxetine on Supine Hypertension: An Ambulatory Blood Pressure Monitoring Study."
-
Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of Theravance BioPharma. Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of 23andMe.
-
Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Healthware. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Stopp-HSP. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otto Loewi Society. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial . Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Alessandra Fanciulli, MD, PhD has received research support from Parkinson Fond. The institution of Alessandra Fanciulli, MD, PhD has received research support from Tuba Foundation. The institution of Alessandra Fanciulli, MD, PhD has received research support from MSA Coalition. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Exchange Programme. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Science Fund. Alessandra Fanciulli, MD, PhD has received publishing royalties from a publication relating to health care.
-
Mr. Guerin has received personal compensation for serving as an employee of Theravance Biopharma.
-
Ross Vickery has nothing to disclose.
-
Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
-
Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theravance biopharma. Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance biopharma. The institution of Dr. Biaggioni has received research support from Theravance biopharma.
-
Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck.